Aquatic Capital Management LLC Rhythm Pharmaceuticals, Inc. Transaction History

Aquatic Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$39.12 - $52.44 $336,432 - $450,984	8,600 New	8,600 $372,000
Q3 2023 Nov 14, 2023	BUY	$15.81 - $27.8 $49,011 - $86,180	3,100 New	3,100 $71,000
Q2 2022 Aug 15, 2022	BUY	$3.12 - $12.25 $6,240 - $24,500	2,000 Added 666.67%	2,300 $10,000
Q1 2022 May 16, 2022	SELL	$6.13 - $12.24 $22,681 - $45,288	-3,700 Reduced 92.5%	300 $3,000
Q4 2021 Feb 14, 2022	BUY	$8.62 - $13.9 $34,480 - $55,600	4,000 New	4,000 $40,000

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.